Citigroup Inc Seagen Inc. Call Options Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 09, 2023	BUY	$191.51 - $216.16 $28.7 Million - $32.4 Million	150,000 New	150,000 $31.8 Million
Q1 2023 May 11, 2023	SELL	$127.59 - $203.08 $32.4 Million - $51.6 Million	-254,100 Reduced 87.38%	36,700 $7.43 Million
Q4 2022 Feb 09, 2023	SELL	$117.37 - $139.17 $33.6 Million - $39.8 Million	-286,200 Reduced 49.6%	290,800 $37.4 Million
Q3 2022 Nov 10, 2022	BUY	$135.27 - $180.11 $78.1 Million - $104 Million	577,000 New	577,000 $79 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.